Studies have shown that deleting the gene that produces 12-LO can stop Type 1 diabetes in mice. Studies of donated human beta cells have allowed the researchers to confirm that the enzyme is the cause of beta cell destruction from inflammation. "We've now confirmed that 12-LO is a relevant target in humans, particularly in the pancreas, and will help lead to new therapies," says the EVMS researchers.
http://www.emaxhealth.com/1020/23/35409/targeting-newly-identified-enzyme-could-cure-type-1-diabetes.html
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-1102
Sunday, May 2, 2010
Monday, October 26, 2009
Sertoli cells by Fallarino at University of Perugia
Quote:
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19822646
Paper: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768846/
We report that isolated neonatal porcine Sertoli cells , administered alone in highly biocompatible microcapsules, led to diabetes prevention and reversion in the respective 88 and 81% of overtly diabetic (nonobese diabetic [NOD]) mice, with no need for additional beta cell or insulin therapy. The effect was associated with restoration of systemic immune tolerance and detection of functional pancreatic islets that consisted of glucose-responsive and insulin-secreting cells.
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19822646
Paper: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768846/
Monday, January 19, 2009
Cord Blood by Zhao at University of Illinois at Chicago
Zhao Y, Lin B, Darflinger R, Zhang Y, Holterman MJ, Skidgel RA: Human cord
blood stem cell-modulated regulatory T lymphocytes reverse the
autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS
ONE 2009, 4:e4226
Abstact: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0004226
Full paper: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0004226#
blood stem cell-modulated regulatory T lymphocytes reverse the
autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS
ONE 2009, 4:e4226
Abstact: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0004226
Full paper: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0004226#
Thursday, May 4, 2006
lisofylline and exendin-4 by Yang at University of Virginia
Quote:
in this study we combined lisofylline to suppress autoimmunity and exendin-4 to enhance β-cell proliferation for treating autoimmune-mediated diabetes in the non-obese diabetic (NOD) mouse model. We found that this combined therapy effectively reversed new-onset diabetes within a week of therapy, and even maintained euglycemia up to 145 days after treatment withdrawal.Abstract: http://www.sciencedirect.com/science/article/pii/S0006291X06007066
Subscribe to:
Posts (Atom)